10th Global Drug Delivery & Formulation Summit

11th – 13th March 2019 | Berlin

Innovative solutions to the greatest challenges in pharmaceutical development

Thanks to everyone who contributed to and attended the DDF Summit 2018.

The agenda covered new technologies, concepts and case studies in areas such as:

  • Less traditional delivery routes including nasal, ocular & subcutaneous
  • Targeted and controlled release technologies and nanoparticles
  • Increasing stability of amorphous solid dispersions
  • QbD in biopharmaceutical development
  • Formulation strategies for multiple injection dosing
  • Oral delivery of peptides
  • Continuous manufacturing and processing for improved efficiency
  • User friendly technologies for improving patient convenience and compliance
  • Regulatory strategies for combination products
  • Drug stability and material selection in combination products

If you’re interested in attending in 2019 as either an attendee, speaker or commercial partner, please get in touch.

2018 POST EVENT REPORT

2018 Speakers

Dr. Amrit Paudel

Graz University of Technology

Assistant Professor Institute of Process and Particle Engineering

Andreas Bernkop-Schnürch

University of Innsbruck

Professor

Aniket Badkar

Allergan

Associate Director Biologics Product Development

Dr Bastiaan Dickhoff

DFE Pharma

Product Application Specialist OSD

Bernard van Eerdenbrugh

Novartis

Pre-clinical Formulation Expert, Chem. & Pharmaceut. Profiling Technical R&D

Bernd Riebesehl

Novartis Pharma AG

Distinguished Fellow

Bjørg Hunter

GlaxoSmithKline

Device Engineering Manager

Carsten Olbrich

Bayer

Product Quality Steward Eylea and Anetumab Ravstantine

Brian Henry

Pfizer

Vice President Drug Product Design

Richard Wedge

Pfizer Ltd

Compliance Lead

Dr. Christian Lotz

Pfanstiehl

Director, Business Development

Christoph Brandenbusch

University of Dortmund

Associate Professor

Clive Wilson

University of Strathclyde

J.P. Professor of Pharmaceutics

Daniel Schweizer

Novartis

DP Project Lead TD NBE’s

Professor Duncan Craig

UCL School of Pharmacy

Director, Chair in Drug Delivery

Filippos Kesisoglou

MSD

Senior Principal Scientist, Biopharmaceutics and Pharmaceutical Sciences

Fred Monsuur

W.R. Grace

TCS and Business Development Manager Excipients

Hannah Batchelor

University of Birmingham

Senior Lecturer in Pharmaceutics, Formulation and Drug Delivery

Helen Hao Hou

Genentech

Scientist, Small Molecule Pharmaceutical Sciences

Helen Williams

AstraZeneca

Associate Principal Scientist

Herve Barre

BD Medical Pharmaceutical Systems

Chef de projet Sterilisation WW, Industrial Engineer

James A. McCoy

BD Medical Pharmaceutical Systems

Staff Scientist, Head of Sterilization R&D/Innovation Center

Jatin Patel

Bristol-Myers Squibb

Head – Oral Product Design & Development

Jean-René Authelin

Sanofi

Global director of Pharmaceutical Engineering

Jerome Mantanus

UCB

Head of Formulation and Process Characterisation

Joel Richard

Ipsen

Senior Vice President, Peptides

Juan Irache

University of Navarra

Professor of Pharmaceutical Technology

Jukka Rantanen

University of Copenhagen

Professor Pharmaceutical Technology

Prof. Dr. Karsten Mäder

Martin Luther University Halle-Wittenberg

Head of Pharmaceutical Technology

Kaspar van den Dries

Patheon, Part of Thermo Fisher Scientific

Senior Director and Principle Scientist, Solid Dose Development

Kathrin Spielberger

Sanofi

Lab Head Formulation Development

Kenneth Graham

Regeneron

Senior Fellow Scientist, Associate Director

Kristof Kimpe

Janssen Pharmaceutica (a division of Johnson & Johnson)

Principal Scientist

Lorenz Meinel

Wurzburg University

Chair for Drug Formulation and Delivery

Márcio Temtem

Hovione

Associate Director for Drug Product Development

Manfred Ogris

Division of Clinical Pharmacy and Diagnostics Vienna University

Professor Pharmaceutical Sciences, Head of the Laboratory for Macromolecular Cancer Therapeutics

Markus Krummer

Novartis

Head of Continuous Manufacturing

Martin McLoughlin

Bristol-Myers Squibb

Head of Device Development

Dr. Matthias Rischer

Losan Pharma

Director Drug Delivery & Innovation Projects

Mike Hooven

Enable Injections, Inc.

President and CEO

Muriel Didier

Novartis

Human Factors Team Head

Nikki Whitfield

Quotient Sciences

Vice President CDMO Services

Olaf Queckenberg

Bayer AG

Head of Chemical & Pharmaceutical Development

Olivier Brass

Sanofi Pasteur

Formulation Scientist

Philippe Lienard

Sanofi

CMC Discovery Coordinator

Rene Van Nostrum

Utrecht University

Associate Professor

Robert Meyer

MSD

Head of Innovation Technology Group, Pharmaceutical Commercialization

Prof. Dr. Sarah Hedtrich

Freie Universitat Berlin

Professor

Sofiya Yashchuk

Roquette

Technical Applications Specialist

Stephen Buckley

Novo Nordisk

Head of Department, Absorption and Biological MS

Surendera Tyagi

Fresenius Kabi USA

Senior Vice President Head Innovation & Development Center

Svend Ludvigsen

Novo Nordisk

Senior Scientific Director

Prof. Dr. Sven Stegemann

Lonza

Director Pharmaceutical Business Development

Tarik Khan

Roche

Group Leader, Late-Stage Pharmaceutical and Processing Development

Thakur Raj Singh

Queen's University Belfast

Senior Lecturer in Pharmaceutics

Thomas Rades

University of Copenhagen

Chair Pharmaceutical Sciences

Vladimir P. Torchilin

Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University

Distinguished Professor and Director

Yash Kapoor

MSD

Associate Principal Scientist

Yves Robin

PMC Isochem (PMC Group)

R&D Director

Yvonne Perrie

University of Strathclyde

Chair Drug Delivery

Gabriele Sadowski

TU Dortmund University

Faculty Head

Frantz Elbaz

Novartis

Formulator Project Leader and Pharm Development QBD Network Leader

Giustino Di Pretoro

Johnson & Johnson

Associate Director

Scott Ariagno

Shire

Head, Infusion and Reconstitution Systems / Director, Device Development and External Manufacturing

Dr. Jin Wang-Lai

Adare Pharma

Senior Director - Pharmaceutical Development

Carina Van Eester

Datwyler Sealing Solutions

Platform leader PFS and cartridges

Wolfgang Beier

Leon-nanodrugs

CSO

Sabine Eichling

Abbvie

Senior Scientist II, NBE High-Throughput and Advanced Formulation Sciences

Joe Barco

Unchained Labs

Senior Director of Marketing

Patrick Garidel

Boehringer Ingelheim

Associate Director Protein Science

Bertil Abrahamsson

Astrazeneca

Senior Principal Scientist

Tonio Hoche

Roche Switzerland

Device Engineer

Mostafa Nakach

Sanofi

Head of Pharmaceutical engineering-Paris

Ellen Verheyen

Janssen

Senior scientist – Stability Expert

Bastiaan de Leeuw

Cambridge Design Partnership

Head of Business Development – Drug Delivery

Gunilla Petersson

Astrazeneca Sweden

Science & Innovation Director

Eleonora Cerasoli

Albumedix

Senior Research Scientist

Tom Lawrie-Fussey

Cambridge Design Partnership

Digital Services Specialist

Ruchi Gupta

MedImmune

Scientist I

Isabel Sequeira Lopes

Chiesi

Senior Formulation Scientist/Project Coordinator

Dr. Meinolf Brackhagen

Dow Chemical Company

Senior TS&D Scientist / Pharma

Dr. Roberto Castangia

biopharma group

Global Sales Manager

Stéphanie Bureau

ADM-SIO

R&D Director

Richard Featherstone

Medical Device Usability Ltd

Managing Director

Patrick Anquetil

Portal Instruments

CEO

Gregoire Schwach

EU F. Hoffmann-La Roche

Head of Drug Delivery, Pharmaceutical Development and Supplies Biologics

Dr. Finn Bauer

Merck KGaA

Head of Solid Formulations R&D

Swapnil Khadke

University of Strathclyde

Pharmaceutical Formulation and Development Specialist

Professor Edward Hæggström

Nanoform

Chief Executive Officer

Richard Zajicek

GSK

Head of Formulation Development, Cell and Gene Therapy Group

Christophe Tistaert

Janssen Belgium

Senior Scientist

Anette Müllertz

University of Copenhagen

Professor, Head of Center